Patent application number | Description | Published |
20080206190 | Glycosylated IL-7, Preparation And Uses - The present invention relates to new and improved interleukin-7 polypeptides, as well as compositions comprising the same, their preparation and uses. The invention more particularly relates to hyperglycosylated IL-7 polypeptides having improved properties, as well as their manufacture and therapeutic uses. The invention also discloses novel IL-7 polypeptides having modified amino acid sequences containing artificially created glycosylation site(s), as well as corresponding nucleic acid molecules, vectors and recombinant host cells. The invention also relates to the use of such polypeptides, cells or nucleic acids for curative or preventive treatment of mammalian subjects, including human subjects. | 08-28-2008 |
20100196312 | GLYCOSYLATED IL-7, PREPARATION AND USES - The present invention relates to new and improved interleukin-7 polypeptides, as well as compositions comprising the same, their preparation and uses. The invention more particularly relates to hyperglycosylated IL-7 polypeptides having improved properties, as well as their manufacture and therapeutic uses. The invention also discloses novel IL-7 polypeptides having modified amino acid sequences containing artificially created glycosylation site(s), as well as corresponding nucleic acid molecules, vectors and recombinant host cells. The invention also relates to the use of such polypeptides, cells or nucleic acids for curative or preventive treatment of mammalian subjects, including human subjects. | 08-05-2010 |
20120016104 | GLYCOSYLATED IL-7, PREPARATION AND USES - The present invention relates to new and improved interleukin-7 polypeptides, as well as compositions comprising the same, their preparation and uses. The invention more particularly relates to hyperglycosylated IL-7 polypeptides having improved properties, as well as their manufacture and therapeutic uses. The invention also discloses novel IL-7 polypeptides having modified amino acid sequences containing artificially created glycosylation site(s), as well as corresponding nucleic acid molecules, vectors and recombinant host cells. The invention also relates to the use of such polypeptides, cells or nucleic acids for curative or preventive treatment of mammalian subjects, including human subjects. | 01-19-2012 |
Patent application number | Description | Published |
20090164875 | System and method for providing a web event channel player - Embodiments of the present invention provide systems and methods for providing access to an channel via an embedded web event channel player. In exemplary embodiments, an embeddable code associated with the channel is provided to a channel owner. Once embedded, the code will provide an instance of the channel player on a user's device that can access the channel. A list of events is aggregated and provided for the channel associated with the channel player. Upon a request by a user, an event from the list of events may be streamed to the channel player. | 06-25-2009 |
20100058410 | System and method for self management of a live web event - A system, method, and computer program for self management of a live web event is provided. In exemplary embodiments, an individual associated with a channel may schedule a web event. Upon scheduling, a user, such as one or more presenters, may be provided a management interface through which content may be prepared for the live web event during a self preparation process. In exemplary embodiments, the user may upload content (e.g., images such as slides) and generate content (e.g., polling questions and answers) autonomously. | 03-04-2010 |
20120158888 | System and Method for Distributing Web Events Via Distribution Channels - A system, method, and computer program for distributing web events via distribution channels are provided. A web event is established in an origination channel. One or more parameters associated with the web content may be identified. The web event is then added to one or more distribution channels based on the one or more parameters. The web event is then distributed to one or more identified users via the one or more distribution channels. | 06-21-2012 |
20120191582 | Lead Generation For Content Distribution Service - A content distribution service may provide lead information to content providers or other entities associated with a broadcast. The service may include both registered and unregistered (e.g., anonymous) users or subscribers that may each provide data associated with one or more subscriber attributes. Subscriber attribute information may be collected from a subscriber in a progressive manner such that sequentially small portions of data are collected over a period of time. The content distribution service may generate leads by collecting and determining subscriber attributes for each subscriber or anonymous user associated with the service. The leads may be generated in response to a request by a content provider or other requestor, or in response to an event such as the creation of a new broadcast. | 07-26-2012 |